MicroRNA-451a Downregulation in Liraglutide-treated Individuals with Diabetes: A Potential Cardiovascular Protective Mechanism

Overview

Journal Diab Vasc Dis Res

Publisher Sage Publications

Specialty Cardiology & Vascular Diseases

Date 2024 Sep 26

PMID 39325062

Authors

Surachai Kongrat

Titiwat Sungkaworn

Chatchai Muanprasat

Chutintorn Sriphrapradang

Teerapat Yingchoncharoen

Affiliations

Soon will be listed here.

References

Ouimet M, Ediriweera H, Afonso M, Ramkhelawon B, Singaravelu R, Liao X . microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2017; 37(6):1058-1067. PMC: 5494696. DOI: 10.1161/ATVBAHA.116.308916. View

Chen H, Untiveros G, McKee L, Perez J, Li J, Antin P . Micro-RNA-195 and -451 regulate the LKB1/AMPK signaling axis by targeting MO25. PLoS One. 2012; 7(7):e41574. PMC: 3402395. DOI: 10.1371/journal.pone.0041574. View

Zhang Q, Xiao X, Zheng J, Li M . A glucagon-like peptide-1 analog, liraglutide, ameliorates endothelial dysfunction through miRNAs to inhibit apoptosis in rats. PeerJ. 2019; 7:e6567. PMC: 6408912. DOI: 10.7717/peerj.6567. View

Marso S, Daniels G, Brown-Frandsen K, Kristensen P, Mann J, Nauck M . Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016; 375(4):311-22. PMC: 4985288. DOI: 10.1056/NEJMoa1603827. View

Mohr A, Mott J . Overview of microRNA biology. Semin Liver Dis. 2015; 35(1):3-11. PMC: 4797991. DOI: 10.1055/s-0034-1397344. View

Kohlstedt K, Trouvain C, Boettger T, Shi L, Fisslthaler B, Fleming I . AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143/145. Circ Res. 2013; 112(8):1150-8. DOI: 10.1161/CIRCRESAHA.113.301282. View

Lucas T, Bonauer A, Dimmeler S . RNA Therapeutics in Cardiovascular Disease. Circ Res. 2018; 123(2):205-220. DOI: 10.1161/CIRCRESAHA.117.311311. View

Ruknarong L, Boonthongkaew C, Chuangchot N, Jumnainsong A, Leelayuwat N, Jusakul A . Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress. PeerJ. 2021; 9:e10776. PMC: 7868066. DOI: 10.7717/peerj.10776. View

Poller W, Dimmeler S, Heymans S, Zeller T, Haas J, Karakas M . Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. Eur Heart J. 2017; 39(29):2704-2716. PMC: 6454570. DOI: 10.1093/eurheartj/ehx165. View

10.

Kuwabara Y, Horie T, Baba O, Watanabe S, Nishiga M, Usami S . MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Circ Res. 2014; 116(2):279-88. DOI: 10.1161/CIRCRESAHA.116.304707. View

11.

Radbakhsh S, Sathyapalan T, Banach M, Sahebkar A . Incretins and microRNAs: Interactions and physiological relevance. Pharmacol Res. 2020; 153:104662. DOI: 10.1016/j.phrs.2020.104662. View

12.

An J, Chen Z, Ma Q, Li Y, Shi F . Liraglutide improves atherosclerosis by regulating long non-coding RNA RMRP/miR-128-1-5P/Gadd45g axis. Eur Rev Med Pharmacol Sci. 2020; 24(5):2725-2737. DOI: 10.26355/eurrev_202003_20545. View

13.

Turczynska K, Bhattachariya A, Sall J, Goransson O, Sward K, Hellstrand P . Stretch-sensitive down-regulation of the miR-144/451 cluster in vascular smooth muscle and its role in AMP-activated protein kinase signaling. PLoS One. 2013; 8(5):e65135. PMC: 3660603. DOI: 10.1371/journal.pone.0065135. View

14.

Bushati N, Cohen S . microRNA functions. Annu Rev Cell Dev Biol. 2007; 23:175-205. DOI: 10.1146/annurev.cellbio.23.090506.123406. View